MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer (Q35145305)

6 August 2017

MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer (English)

1 reference

6 August 2017

1 reference

Xi-Xue Zhao

1

1 reference

6 August 2017

Qing-Zhong Yuan

2

1 reference

6 August 2017

Dong-Po Mu

3

1 reference

6 August 2017

Di-Wen Sun

4

1 reference

6 August 2017

Qing-Ao Bo

5

1 reference

6 August 2017

Guo-Zheng Pan

6

1 reference

6 August 2017

Guo-Qiang Li

7

1 reference

6 August 2017

Tao Cui

8

1 reference

6 August 2017

Peng-Peng Ding

9

1 reference

6 August 2017

Fa-Ping You

10

1 reference

6 August 2017

Long Hao

11

1 reference

6 August 2017

Ming-Xin Wang

12

1 reference

6 August 2017

Jian Zhang

13

1 reference

6 August 2017

1 January 2015

1 reference

International Journal of Clinical and Experimental Pathology

6 August 2017

1 reference

6 August 2017

8

1 reference

6 August 2017

1

1 reference

6 August 2017

368-373

1 reference

The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

The role of microRNAs in human breast cancer progression

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

Colorectal cancer statistics, 2014.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

High mobility group A1 and cancer: potential biomarker and therapeutic target

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

MicroRNAs and cancer: short RNAs go a long way.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

Roles of HMGA proteins in cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

MicroRNA signatures in human cancers

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

MicroRNAs: genomics, biogenesis, mechanism, and function

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348937

13 July 2018

Identifiers

PMCID

4348937

1 reference

6 August 2017

1 reference